Since gluconeogenesis biochemically opposes glucose catabolism, we hypothesized that glucagon signaling would have a tumor suppressive effect in liver cancer cells that are responsive to glucagon, especially if they express sufficient levels of GCGR and key gluconeogenic enzymes. Here, GCG is linked to liver cancer.